Orlando, FL (PRWEB) January 10, 2013
The prescription resource center DrugRisk.com has added information to its comprehensive database for women using the vaginal ring contraceptive NuvaRing which shows the number of claims filed over blood clot injuries has increased.
The mission of DrugRisk is to improve patient safety through education, including the latest drug warnings, recalls, studies and litigation news. In many cases visitors want litigation information to know if others are experiencing similar problems and whether they have any options, explains DrugRisk representative Ryan Mayer.
DrugRisk previously added warnings from experts that vaginal rings like NuvaRing may be linked to higher blood clot risks than traditional birth control pills.
The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.
Now, the resource center has learned that the number of NuvaRing lawsuits filed over blood clots has risen by nearly 5% to 1076 from the last report, according to the U.S. Judicial Panel on MultiDistrict Litigation.*
Due to the number of claims, cases have been consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
Anyone who suffered NuvaRing blood clots, stroke, DVT or pulmonary embolism is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.